Noboru Watanabe Selected Research

Noboru Watanabe Research Topics

Disease

6	Heart Failure 10/2021 - 09/2005
5	Myocardial Infarction 10/2021 - 01/2015
4	Neoplasms (Cancer) 05/2022 - 03/2014
4	Stroke (Strokes) 07/2017 - 01/2016
3	Hemorrhage 01/2021 - 03/2017
3	Ulcer 02/2018 - 04/2006
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2017 - 01/2016
2	Communicable Diseases (Infectious Diseases) 05/2022 - 01/2020
2	Atrial Fibrillation 10/2021 - 07/2017
2	Neoplasm Metastasis (Metastasis) 02/2020 - 02/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2015
2	Death (Near-Death Experience) 01/2018 - 07/2017
2	Diarrhea 01/2013 - 03/2005
1	Pathologic Constriction (Stenosis) 07/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2022
1	Inflammation (Inflammations) 07/2022
1	Infections 05/2022
1	Body Weight (Weight, Body) 03/2022
1	Chronic Renal Insufficiency 10/2021
1	Acute Kidney Injury (Acute Renal Failure) 10/2021
1	Ulcerative Colitis 04/2021
1	Disease Progression 04/2021
1	Thromboembolism 01/2021
1	Cellulitis 08/2018
1	Gastritis 08/2018
1	Bacteremia 08/2018
1	Hepatocellular Carcinoma (Hepatoma) 02/2018
1	Actinomycosis 02/2018
1	Thrombosis (Thrombus) 07/2017
1	Acute Coronary Syndrome 03/2017
1	Colitis 11/2016
1	Ileus 01/2015
1	Ischemic Stroke 01/2015
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 02/2014
1	Abscess 02/2014
1	Duodenal Ulcer (Curling's Ulcer) 01/2013
1	Fistula 01/2013
1	Pain (Aches) 04/2006
1	Erectile Dysfunction 02/2006
1	Pulmonary Hypertension 02/2006
1	Myocarditis (Carditis) 09/2005
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 09/2005
1	Pre-Eclampsia (Preeclampsia) 03/2005
1	Hemolysis 03/2005

Drug/Important Bio-Agent (IBA)

6	omega-Chloroacetophenone (Mace)IBA 10/2021 - 01/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2018 - 02/2014
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	Leucine (L-Leucine)FDA Link 07/2022
1	Glycoproteins (Glycoprotein)IBA 07/2022
1	SuspensionsIBA 05/2022
1	pro-brain natriuretic peptide (1-76)IBA 03/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2022
1	Mesalamine (Mesalazine)FDA LinkGeneric 04/2021
1	Proton Pump InhibitorsIBA 04/2021
1	AcidsIBA 04/2021
1	Reducing AgentsIBA 04/2021
1	AnticoagulantsIBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Anaplastic Lymphoma KinaseIBA 02/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 08/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2018
1	Ampicillin (Omnipen)FDA LinkGeneric 02/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2016
1	Dextrans (Dextran)FDA Link 11/2016
1	CateninsIBA 11/2016
1	SodiumIBA 01/2015
1	Meglumine FDA Link 01/2015
1	Diatrizoate (Hypaque)FDA LinkGeneric 01/2015
1	Natriuretic PeptidesIBA 10/2008
1	5-methoxy-methylindoleacetic acid (DBI)IBA 04/2006
1	Vardenafil Dihydrochloride (Levitra)FDA Link 02/2006
1	Sildenafil Citrate (Viagra)FDA Link 02/2006
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 02/2006
1	Phosphodiesterase 5 InhibitorsIBA 02/2006
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2005
1	OsteopontinIBA 09/2005
1	Messenger RNA (mRNA)IBA 09/2005
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2005
1	Ceftazidime (Fortum)FDA LinkGeneric 03/2005
1	Cefotaxime (Kendrick)FDA LinkGeneric 03/2005
1	Captopril (Capoten)FDA LinkGeneric 03/2005

Therapy/Procedure

5	Therapeutics 01/2021 - 09/2005
4	Percutaneous Coronary Intervention 10/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 08/2018 - 02/2018
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Bridge Therapy 01/2021
1	Length of Stay 01/2021
1	Enteral Nutrition (Feeding, Tube) 08/2018
1	Oral Administration 02/2018
1	Nursing Care 01/2018
1	Drug-Eluting Stents 07/2017
1	Stents 07/2017
1	Esophagectomy 03/2014
1	Conservative Treatment 02/2014
1	Chemoradiotherapy 02/2014
1	Gastroenterostomy 01/2013
1	Gastrectomy 01/2013